Zhen Jin | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Zhen Jin | Drug Delivery Systems | Best Researcher Award

Assistant Professor at Xinxiang Medical University | China

Dr. Zhen Jin is a distinguished researcher specializing in nanomedicine, controlled drug delivery, and medical micro-nano robots. He completed doctoral and postdoctoral research at the Medical Robotics Research Institute of Chonnam National University, South Korea, before joining Xinxiang Medical College. His innovative work integrates nanodrug design, advanced therapeutic delivery systems, and cancer diagnostics. With more than 30 SCI-indexed publications, including numerous first-author papers, and four granted national invention patents, his contributions continue to influence biomedical science. His pioneering developments in imaging-guided therapy and synergistic nanocomposites highlight his commitment to advancing cancer treatment and medical robotics research globally.

Publication Profile 

Google Scholar

Education 

Dr. Zhen Jin pursued his doctoral degree at the Medical Robotics Research Institute, Chonnam National University, South Korea, where he also completed postdoctoral research. His academic journey provided a strong foundation in interdisciplinary biomedical engineering, robotics, and nanomedicine. During this period, he engaged in multiple national-level projects, honing expertise in medical micro-nano systems and cancer therapy. This rigorous academic training prepared him to advance research in nanodrugs, controlled drug delivery, and medical robotics. Following this, he transitioned to Xinxiang Medical College, where he integrated his educational background into teaching and research to foster innovation in biomedical sciences.

Experience

Dr. Zhen Jin has extensive research and academic experience, beginning with his doctoral and postdoctoral tenure in South Korea, where he contributed to significant national key projects. His expertise spans nanodrug design, micro-nano robotics, and advanced cancer diagnosis and treatment technologies. Currently, he is a faculty member at Xinxiang Medical College, where he leads cutting-edge projects funded by Henan Province. He has successfully published more than 30 SCI papers, authored key innovations, and secured national invention patents. His experience bridges academia and applied research, positioning him as a leader in biomedical nanotechnology and precision therapeutic development.

Awards and Honors

Dr. Zhen Jin has received recognition for his outstanding contributions to biomedical science, particularly in the fields of nanomedicine and cancer therapy. He has successfully participated in national research projects in South Korea and led provincial-level science and technology projects in China. His impactful research has earned him four national invention patents and numerous publications in high-impact SCI journals. His citation index reflects his growing influence in scientific communities, with an h-index of 21. These honors underscore his position as a promising and innovative researcher, making him a strong candidate for the Best Researcher Award.

Research Focus

Dr. Zhen Jin’s research focuses on nanomedicine, controlled drug delivery systems, and micro-nano robotic platforms for cancer therapy. He has developed multifunctional nanocomposites that combine therapeutic delivery with imaging capabilities for precise diagnosis and treatment. His work on DOX-HSP ananotheranostics exemplifies his focus, showcasing biocompatibility, controlled drug release, and imaging-guided multimodal therapy. By integrating photothermal and chemotherapeutic effects, his studies demonstrate enhanced anti-tumor efficacy. His pioneering approach seeks to overcome challenges of premature drug release and tumor-specific targeting, positioning his research at the forefront of personalized medicine, cancer diagnostics, and next-generation biomedical technologies.

Publication Top Notes

Human adipose–derived mesenchymal stem cell–based medical microrobot system for knee cartilage regeneration in vivo

Hybrid-actuating macrophage-based microrobots for active cancer therapy

A magnetically guided self‐rolled microrobot for targeted drug delivery, real‐time X‐Ray imaging, and microrobot retrieval

A thermo-electromagnetically actuated microrobot for the targeted transport of therapeutic agents

A magnetically actuated microscaffold containing mesenchymal stem cells for articular cartilage repair

Multifunctional nanorobot system for active therapeutic delivery and synergistic chemo-photothermal therapy

A hybrid actuated microrobot using an electromagnetic field and flagellated bacteria for tumor‐targeting therapy

A soft-magnet-based drug-delivery module for active locomotive intestinal capsule endoscopy using an electromagnetic actuation system

High-fidelity bioelectronic muscular actuator based on porous carboxylate bacterial cellulose membrane

Dual tumor-targeted multifunctional magnetic hyaluronic acid micelles for enhanced MR imaging and combined photothermal-chemotherapy

Ecofriendly high-performance ionic soft actuators based on graphene-mediated cellulose acetate

Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake

Feasibility study of dual-targeting paclitaxel-loaded magnetic liposomes using electromagnetic actuation and macrophages

Shape memory alloy–based biopsy device for active locomotive intestinal capsule endoscope

Conclusion

Dr. Zhen Jin pioneering contributions in nanomedicine, micro-nano robots, and controlled drug delivery make him a highly deserving candidate for the Best Researcher Award. His combination of innovative patents, high-impact publications, and cutting-edge theranostic development reflects exceptional promise for shaping the future of biomedical science. With continued emphasis on clinical translation and international engagement, his work is poised to leave a transformative mark on cancer diagnosis and therapy.

Yilong Wang | Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Yilong Wang | Drug Delivery Systems | Best Researcher Award

Prof Yilong Wang, Beijing Tiantan Hospital, Capital Medical University, China

Dr. Yilong Wang, Executive Vice President of Beijing Tiantan Hospital, Capital Medical University, is a distinguished neurologist and scientist. With an MD and PhD in Neurology, he has pioneered research in stroke and rare neurological disorders. Author of 301 impactful journal articles and holder of 12 patents, his innovative work spans drug delivery systems and precision medicine. Honored with the 2023 Paul Dudley White International Award, he has also authored several clinical neurology manuals. His cutting-edge contributions, including transcranial drug delivery devices, underscore his commitment to advancing global healthcare. 🌍📚

Publication Profile

google scholar

Academic and Professional Background

Professor Yilong Wang 🎓, an accomplished neurologist, earned his MBBS and MSc from North China University of Science and Technology, followed by an MD and PhD in Neurology from Capital Medical University. He completed postdoctoral training at the University of San Francisco 🌉. Currently serving as Executive Vice President and Chief Scientist at Beijing Tiantan Hospital 🏥, Prof. Wang has led groundbreaking research in stroke and rare neurological diseases 🧠. Over the past five years, he has published 72 high-impact papers 📄, holds 12 patents, and made significant strides in precision medicine and drug delivery systems 💊, earning prestigious accolades like the 2023 Paul Dudley White International Award 🏆.

Editorial Appointments

 Professor Yilong Wang 🧑‍⚕️ holds prominent editorial roles, serving as the Assistant Editor-in-Chief of Stroke & Vascular Neurology 📚, Deputy Editor-in-Chief of the Chinese Journal of Cerebrovascular Diseases 🧠, and as an editorial board member of the Chinese Journal of Stroke ✍️. His collaborative efforts extend to leading institutions, including the Frontier Medical Interdisciplinary and Translational Center at the National Center for Neurological Disorders 🌐 and the Beijing Brain Science and Brain-Inspired Research Center 🧬. These partnerships underscore his commitment to advancing neurological research and fostering innovation in cerebrovascular and brain science 🏥.

Professional Memberships

Professor Yilong Wang 🧑‍⚕️ plays key leadership roles in various prestigious organizations. He serves as Vice Chairman of the Expert Committee for the National Health Commission’s Million Disability Reduction Project 🌟, demonstrating his dedication to public health. Prof. Wang is also the Deputy Leader of the Youth Group of the 8th Committee of the Neurology Branch of the Chinese Medical Association 🧠. Additionally, he is the Executive Vice Chairman of the Youth Working Committee of the Chinese Stroke Association 💼 and Vice Chairman of the Cerebral Small Vessel Disease Branch of the Chinese Stroke Association 🩺, driving innovation in neurological care.

Areas of Research

Professor Yilong Wang 🧑‍⚕️ specializes in clinical and translational research on cerebrovascular diseases and rare neurological disorders 🧠, with a focus on interdisciplinary medical-engineering innovations ⚙️. His research includes precision medicine for ischemic stroke 🩺, developing technologies for accurate diagnosis and treatment. He pioneers innovative drug delivery systems 💊, utilizing skull bone marrow-dura-lymphatic pathways to bypass the blood-brain barrier for safe intracranial drug delivery. Prof. Wang also investigates the pathogenesis, diagnostics, and interventions for cerebral small vessel disease and rare neurological disorders 🌐. Additionally, he advances intelligent skull flaps, smart drug delivery systems, and brain-computer interfaces 🤖.

Contributions

Professor Yilong Wang 🧑‍⚕️, a renowned neurologist at Beijing Tiantan Hospital 🏥, has revolutionized stroke and rare neurological disease research 🧠. Over the past five years, he has published 72 high-impact papers in top journals like NEJM, JAMA, and BMJ 📄 and holds 12 patents, with 2 successfully translated into clinical applications 🌟. His innovations include extending the time window for dual antiplatelet therapy, developing drugs for microcirculation disorders, and pioneering skull-based drug delivery systems to bypass the blood-brain barrier 💊. Recipient of the 2023 Paul Dudley White International Award 🏆, Prof. Wang has advanced precision medicine and rare disease research, improving global patient care 🌍.

Research Focus

Professor Yilong Wang is a distinguished researcher focusing on neurology, particularly stroke epidemiology, prevention, and management, and the application of artificial intelligence (AI) in healthcare. His work spans from analyzing stroke prevalence in China to exploring treatment strategies, including antiplatelet therapies and real-world applications of AI in medical practice. With a robust emphasis on stroke prevention, outcomes, and treatment innovation, his contributions bridge advanced research and clinical practice. Wang’s research also addresses the broader implications of healthcare technologies, underscoring their transformative potential. 🧠💊📊

Publication Top Notes

Artificial intelligence in healthcare: past, present and future

Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults

Clopidogrel with aspirin in acute minor stroke or transient ischemic attack

Stroke in China: advances and challenges in epidemiology, prevention, and management

Near-real-time monitoring of global CO2 emissions reveals the effects of the COVID-19 pandemic

Rivaroxaban for stroke prevention after embolic stroke of undetermined source

Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese Intracranial Atherosclerosis (CICAS) Study

Summer soil drying exacerbated by earlier spring greening of northern vegetation